The U.S. is slashing funding for scientific research, after decades of deep investment. Here’s some of what those taxpayer dollars created.
Category: Premature Babies
-
He Fought Claims of Harm From Infant Formula. Now He Regulates It.
Kyle Diamantas, a former corporate lawyer, is the new director for the F.D.A. food division, which oversees infant formula. He defended a top maker in cases claiming the company had not warned of potential risks to very low-weight babies.
-
Preterm Birth Drug Withdrawn After 12 Years
The F.D.A. seemed poised to rescind approval of Makena, after studies over time indicated the treatment did not halt early childbirth for many women.
-
FDA Panel Recommends Pulling Preterm Birth Drug From the Market
The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.